Cardiovascular screening programme in the Central Hungarian region. The Budakalász Study;Cardiovascularis szuroprogram a közép-magyarországi régióban. Budakalász Vizsgálat

Orvosi Hetilap

Volumn 155, Issue 34, 2014, Pages 1344-1352

  Bagyura, Zsolt ^a   Kiss, Loretta ^a   Édes, Eszter ^a   Lux, Árpád ^a   Polgár, Lívia ^a   Soós, Pál ^a   Szenczi, Orsolya ^a   Szelid, Zsolt ^a   Vadas, Réka ^a   Józan, Péter ^b   Bagdy, György ^a   Merkely, Béla ^a  

^a SEMMELWEIS UNIVERSITY   (Hungary)

^b INSTITUTE OF EXPERIMENTAL MEDICINE   (Hungary)

Author keywords

cardiovascular; cardiovascularis; kock zatbecsl s; morbidit s; morbidity; risk stratification; screening; szurovizsg lat

Indexed keywords

ADULT; ANKLE BRACHIAL INDEX; ANTHROPOMETRY; ARTICLE; BLOOD PRESSURE MEASUREMENT; BLOOD SAMPLING; CARDIOVASCULAR RISK; CARDIOVASCULAR SYSTEM EXAMINATION; ECHOCARDIOGRAPHY; FEMALE; HEALTH PROGRAM; HEALTH STATUS; HUMAN; LABORATORY TEST; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MASS SCREENING; MIDDLE AGED; MORBIDITY; QUESTIONNAIRE; VENOUS BLOOD; AGE DISTRIBUTION; AGED; BODY MASS; CARDIOVASCULAR DISEASES; COMPLICATION; DIABETES COMPLICATIONS; EPIDEMIOLOGY; HUNGARY; HYPERLIPIDEMIAS; HYPERTENSION; PROGRAM EVALUATION; RISK FACTOR; SEX RATIO; SMOKING; VERY ELDERLY;

ADULT; AGE DISTRIBUTION; AGED; AGED, 80 AND OVER; BODY MASS INDEX; CARDIOVASCULAR DISEASES; DIABETES COMPLICATIONS; FEMALE; HUMANS; HUNGARY; HYPERLIPIDEMIAS; HYPERTENSION; MALE; MASS SCREENING; MIDDLE AGED; PROGRAM EVALUATION; RISK FACTORS; SEX DISTRIBUTION; SMOKING;

EID: 84906274799     PISSN: 00306002     EISSN: 17886120     Source Type: Journal    
DOI: 10.1556/OH.2014.29969     Document Type: Article

References (27)

1. National Statistical Office: Demographic portrait 2012. Report of the Hungarian population. [Központi Statisztikai Hivatal: Demográfiai Portré 2012. Jelentés a magyar népesség helyzetérŒl.] KSH Népességtudományi Kutatóintézet, Budapest, 2012. [Hungarian]
2. Perk, J., De Backer, G., Gohlke, H., et al.: European guidelines on cardiovascular disease prevention in clinical practice (version 2012). The Fifth Joint Task Force of the European Society of Cardiology and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of nine societies and by invited experts). Eur. Heart. J., 2012, 33(33), 1635-1701.
3. Dawber, T. R., Meadors, G. F., Moore, F. E., Jr.: Epidemiological approaches to heart disease: the Framingham Study. Am. J. Public Health Nations Health, 1951, 41(3), 279-281.
4. D'Agostino, R. B., Sr., Vasan, R. S., Pencina, M. J., et al.: General cardiovascular risk profile for use in primary care: the Framingham Heart Study. Circulation, 2008, 117(6), 743-753.
5. Borch-Johnsen, K., Feldt-Rasmussen, B., Strandgaard, S., et al.: Urinary albumin excretion. An independent predictor of ischemic heart disease. Arterioscler. Thromb. Vasc. Biol., 1999, 19(8), 1992-1997.
6. Li, Y., Lu, J., Wu, X., et al.: Serum uric acid concentration and asymptomatic hyperuricemia with subclinical organ damage in general population. Angiology, 2013 Dec 9. [Epub ahead of print]
7. Storhaug, H. M., Norvik, J. V., Toft, I., et al.: Uric acid is a risk factor for ischemic stroke and all-cause mortality in the general population: a gender specific analysis from The Tromsø Study. BMC Cardiovasc. Disord., 2013, 13, 115.
8. Clarke, R., Halsey, J., Lewington, S., et al.: Effects of lowering homocysteine levels with B vitamins on cardiovascular disease, cancer, and cause-specific mortality: Meta-analysis of 8 randomized trials involving 37 485 individuals. Arch. Intern. Med., 2010, 170(18), 1622-1631.
9. Kaptoge, S., Di Angelantonio, E., Lowe, G., et al.: C-reactive protein concentration and risk of coronary heart disease, stroke, and mortality: an individual participant meta-analysis. Lancet, 2010, 375(9709), 132-140.
10. Kaptoge, S., White, I. R., Thompson, S. G., et al.: Associations of plasma fibrinogen levels with established cardiovascular disease risk factors, inflammatory markers, and other characteristics: individual participant meta-analysis of 154,211 adults in 31 prospective studies: the fibrinogen studies collaboration. Am. J. Epidemiol., 2007, 166(8), 867-879.
11. Grandi, N. C., Breitling, L. P., Brenner, H.: Vitamin D and cardiovascular disease: systematic review and meta-analysis of prospective studies. Prev. Med., 2010, 51(3-4), 228-233.
12. Wang, T. J., Larson, M. G., Levy, D., et al.: Plasma natriuretic peptide levels and the risk of cardiovascular events and death. N. Engl. J. Med., 2004, 350(7), 655-663.
13. Ross, R.: Atherosclerosis - an inflammatory disease. N. Engl. J. Med., 1999, 340(2), 115-126.
14. Frostegård, J.: Immunity, atherosclerosis and cardiovascular disease. BMC Med., 2013, 11, 117.
15. Haberl, R., Becker, A., Leber, A., et al.: Correlation of coronary calcification and angiographically documented stenoses in patients with suspected coronary artery disease: results of 1,764 patients. J. Am. Coll. Cardiol., 2001, 37(2), 451-457.
16. Cobble, M., Bale, B.: Carotid intima-media thickness: knowledge and application to everyday practice. Postgrad. Med., 2010, 122(1), 10-18.
17. Aboyans, V., Criqui, M. H., Abraham, P., et al.: Measurement and interpretation of the Ankle-Brachial Index: a scientific statement from the American Heart Association. Circulation, 2012, 126(24), 2890-2909.
18. Lemieux, I., Lamarche, B., Couillard, C., et al.: Total cholesterol/HDL cholesterol ratio vs LDL cholesterol/HDL cholesterol ratio as indices of ischemic heart disease risk in men: the Quebec Cardiovascular Study. Arch. Intern. Med., 2001, 161(22), 2685-2692.
19. Lindström, J., Tuomilehto, J.: The diabetes risk score: a practical tool to predict type 2 diabetes risk. Diabetes Care, 2003, 26(3), 725-731.
20. Agatston, A. S., Janowitz, W. R., Hildner, F. J., et al.: Quantification of coronary artery calcium using ultrafast computed tomography. J. Am. Coll. Cardiol., 1990, 15(4), 827-832.
21. Sarwar, A., Shaw, L. J., Shapiro, M. D., et al.: Diagnostic and prognostic value of absence of coronary artery calcification. JACC Cardiovasc. Imaging, 2009, 2(6), 675-688.
22. Budoff, M. J., Shaw, L. J., Liu, S. T., et al.: Long-term prognosis associated with coronary calcification: observations from a registry of 25,253 patients. J. Am. Coll. Cardiol., 2007, 49(18), 1860-1870.
23. Touboul, P. J., Hennerici, M. G., Meairs, S., et al.: Mannheim carotid intima-media thickness and plaque consensus (2004-2006-2011). An update on behalf of the advisory board of the 3rd, 4th and 5th watching the risk symposia, at the 13th, 15th and 20th European Stroke Conferences, Mannheim, Germany, 2004, Brussels, Belgium, 2006, and Hamburg, Germany, 2011. Cerebrovasc. Dis., 2012, 34(4), 290-296.
24. Diagnosis and classification of diabetes mellitus. Diabetes Care, 2014, 37(Suppl. 1), S81-S90.
25. National Statistical Office: Health Survey Statistics 2009. [Statisztikai tükör Egészségfelmérés 2009 (ELEF)] KSH, Budapest, 2010, 4(50), 1-7. [Hungarian]
26. Gallus, S., Lugo, A., La Vecchia, C., et al.: Pricing Policies And CONTROL of Tobacco in Europe (PPACTE) project: cross-national comparison of smoking prevalence in 18 European countries. Eur. J. Cancer Prev., 2014, 23(3), 177-185.
27. Ford, E. S., Giles, W. H., Mokdad, A. H.: The distribution of 10-year risk for coronary heart disease among US adults: findings from the National Health and Nutrition Examination Survey III. J. Am. Coll. Cardiol., 2004, 43(10), 1791-1796.